Skip to main content

Table 2 Coefficient of variation (%) of erythrocyte MTX-PG concentrations

From: Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

 

All (n = 18)

Oral MTX (n = 7)

Subcutaneous MTX (n = 12)

MTX-PG1

103.5

42.3

114.0

MTX-PG2

27.2

23.2

29.8

MTX-PG3

49.8

31.0

44.0

MTX-PG4

77.7

45.2

50.7

MTX-PG5

77.0

17.3

50.9

MTX-PGtotal

55.1

30.9

50.0